Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer
Author:
Publisher
Elsevier BV
Subject
Urology
Reference5 articles.
1. Pilepich MV, Caplan R, Byhardt RW, et al: Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of radiation therapy oncology group protocol 85-31. J Clin Oncol 15: 1013–1021, 1997.
2. Pilepich MV, Winter K, Roach M, et al: Phase III radiation therapy oncology group (RTOG) 86-10 of androgen deprivation before and during radiotherapy in locally advanced carcinoma of the prostate [abstract]. J Clin Oncol 17: 308a, 1998, Abstract 1185.
3. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997
4. Hanks GE, Lu J, Machtay M, et al: RTOG Protocol 92-02: a phase III trial of the use of long term androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy for locally advanced carcinoma of the prostate. Proceedings of American Society of Clinical Oncology 2000 [abstract]. J Clin Oncol 19: 327a, 2000, Abstract 1284.
5. D’Amico AV, Schultz D, Loffredo M, et al: Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for men with clinically localized prostate cancer. JAMA 284: 1280–1283, 2000.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biparametric MRI prior to Radical Radiation Therapy for Prostate Cancer in a Caribbean Population: Implications for Risk Group Stratification and Treatment;Radiology: Imaging Cancer;2020-07-01
2. Conceptual review of key themes in treating prostate cancer in older adults;Journal of Geriatric Oncology;2020-06
3. Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure;Frontiers in Oncology;2015-04-14
4. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer;Radiotherapy and Oncology;2004-04
5. The novel Ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro;The Prostate;2004
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3